首页> 外国专利> POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, REDUCED CONCENTRATION OF CHOLESTEROL, ANTI-INFLAMMATIVE EFFECT AND SUSTAINABILITY

POLYBACTERIAL DRUG WITH ADVANTAGES FOR HEALTH: WITH ANTIOXIDANT EFFECT, REDUCED CONCENTRATION OF CHOLESTEROL, ANTI-INFLAMMATIVE EFFECT AND SUSTAINABILITY

机译:具有健康优势的细菌药物:具有抗氧化剂作用,降低的胆固醇浓度,抗炎作用和可持续性

摘要

1. Polybacterial preparation comprising a combination of strains of Lactobacillus gasseri 7/12 NBIMCC No. 8720, Lactobacillus plantarum F12 NBIMCC No. 8722, Lactobacillus helveticus A1 NBIMCC No. 8721.2. The polybacterial preparation according to claim 1, containing living cells in the following amount: at least 10 CFU / g Lactobacillus gasseri 7/12, at least 2 × 10 CFU / g Lactobacillus helveticus A1, and at least 9 × 10 CFU / g Lactobacillus plantarum. 3. The polybacterial preparation according to claim 1, having antioxidant, anti-inflammatory immunomodulatory, hypocholesterolemic and antihypertensive effects. The polybacterial preparation according to claim 1, presented in the form of a lyophilisate or liquid culture. A bacterial preparation containing at least one strain selected from Lactobacillus gasseri 7/12 NBIMCC No. 8720, Lactobacillus plantarum F12 NBIMCC No. 8722 and Lactobacillus helveticus A1 NBIMCC No. 8721.6. The bacterial preparation according to claim 5, presented in the form of a lyophilisate or liquid culture. Strain Lactobacillus gasseri 7/12 NBIMCC No. 8720 with the strain-specific DNA profile shown in FIG. 2, producer of the bacterial preparation. Strain Lactobacillus gasseri 7/12 NBIMCC No. 8720 according to claim 7, a producer of a bacterial preparation having hypocholesterolemic activity and anti-inflammatory immunomodulatory activity. Strain Lactobacillus plantarum F12 NBIMCC No. 8722 with the strain-specific DNA profile shown in FIG. 1, producer of the bacterial preparation. 10. Strain Lactobacillus plantarum F12 NBIMCC No. 8722 according to claim 9, a producer of a bacterial preparation having antioxidant activity. Strain Lactobacillus helveticus A1 NBIMCC No. 8721 with the strain-specific DNA profile shown in FIG. 3, producer of the bacterial preparation. 12. Strain Lactobacillus helveticus A1 NBIMCC No. 8721 according to claim 11, a producer of a bacterial preparation having antihypertensive active
机译:1.一种多细菌制剂,其包含加氏乳杆菌7/12 NBIMCC 8720,植物乳杆菌F12 NBIMCC 8722,瑞士乳杆菌A1 NBIMCC 8721.2的菌株的组合。 2.根据权利要求1所述的细菌制剂,其含有以下量的活细胞:至少10CFU / g加氏乳杆菌7/12,至少2×10CFU / g瑞士乳杆菌A1和至少9×10CFU / g乳杆菌。车前草。 3.根据权利要求1的多细菌制剂,具有抗氧化剂,抗炎免疫调节,降血脂和降压作用。 2.根据权利要求1所述的细菌制剂,其以冻干物或液体培养物的形式存在。一种细菌制剂,其包含至少一种选自加氏乳杆菌7/12 NBIMCC No.8720,植物乳杆菌F12 NBIMCC No.8722和瑞士乳杆菌A1 NBIMCC No.8721.6的菌株。 6.根据权利要求5所述的细菌制剂,其以冻干物或液体培养物的形式存在。具有图7所示的菌株特异性DNA谱的菌株加氏乳杆菌7/12 NBIMCC No.8720。 2,生产者的细菌制剂。 8.根据权利要求7所述的加氏乳杆菌菌株7/12 NBIMCC No.8720,其是具有降胆固醇活性和抗炎免疫调节活性的细菌制剂的生产商。植物菌株乳杆菌F12 NBIMCC No.8722,具有图7所示的菌株特异性DNA谱。 1,生产者的细菌制剂。 10.根据权利要求9的植物乳杆菌F12 NBIMCC No.8722,其是具有抗氧化活性的细菌制剂的生产者。具有图7所示的菌株特异性DNA谱的菌株瑞士乳杆菌Al NBIMCC No.8721。 3,生产细菌的制剂。 12.根据权利要求11所述的瑞士乳杆菌菌株A1 NBIMCC No.8721,其是具有抗高血压活性的细菌制剂的生产商。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号